{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:16:45Z","timestamp":1793888205955,"version":"4.8.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["2\/528\/44"],"award-info":[{"award-number":["2\/528\/44"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cbi.2024.111218","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T21:51:49Z","timestamp":1724795509000},"page":"111218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Alkaloid-based modulators of the PI3K\/Akt\/mTOR pathway for cancer therapy: Understandings from pharmacological point of view"],"prefix":"10.1016","volume":"402","author":[{"given":"Fatima Zohra","family":"Mokhfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Al Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrukh","family":"Zehravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk Hussein","family":"Sweilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uppuluri Varuna Naga Venkata","family":"Arjun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Vallamkonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Dharani","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Salman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koula","family":"Doukani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111218_bib1","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.cbi.2024.111218_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-023-02067-2","article-title":"A critical review and analysis of the context, current burden, and application of policy to improve cancer equity in Ghana","volume":"22","author":"Tuck","year":"2023","journal-title":"Int. J. Equity Health"},{"key":"10.1016\/j.cbi.2024.111218_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211038735","article-title":"Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective","volume":"28","author":"Pi\u00f1a-S\u00e1nchez","year":"2021","journal-title":"Cancer Control"},{"key":"10.1016\/j.cbi.2024.111218_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26134100","article-title":"Targeting the pi3k\/akt\/mtor signaling pathway in lung cancer: an update regarding potential drugs and natural products","volume":"26","author":"Iksen","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111218_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215297","article-title":"PI3K\/Akt\/mTOR signaling pathway in blood malignancies\u2014new therapeutic possibilities","volume":"15","author":"Wiese","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111218_bib6","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib7","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Ningni","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2024.111218_bib8","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2024.111218_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628690","article-title":"Activation of PI3K\/AKT\/mTOR pathway causes drug resistance in breast cancer","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cbi.2024.111218_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22020250","article-title":"Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms","volume":"22","author":"Habli","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111218_bib13","article-title":"Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets","volume":"15","author":"Qin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071836","article-title":"Alkaloids used as medicines: structural phytochemistry meets biodiversity\u2014an update and forward look","volume":"26","author":"Heinrich","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111218_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11110656","article-title":"The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens","volume":"11","author":"Thawabteh","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.cbi.2024.111218_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26133800","article-title":"Alkaloids in contemporary drug discovery to meet global disease needs","volume":"26","author":"Daley","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111218_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cbi.2024.111218_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/akt\/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cbi.2024.111218_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12110713","article-title":"Biological activity of berberine\u2014a summary update","volume":"12","author":"Och","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.cbi.2024.111218_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1248\/bpb.34.1264","article-title":"The \u03b2-carboline alkaloid harmol induces cell death via autophagy but not apoptosis in human non-small cell lung cancer A549 cells","volume":"34","author":"Abe","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2024.111218_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-022-01762-4","article-title":"Matrine induces autophagy in human neuroblastoma cells via blocking the AKT-mTOR pathway","volume":"39","author":"Liu","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.phytol.2021.08.014","article-title":"Camptothecin derivatives induce apoptosis and inhibit proliferation of prostate cancer PC-3M cells through downregulation of PI3K\/Akt signaling pathway","volume":"46","author":"Zhao","year":"2021","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.cbi.2024.111218_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101353","article-title":"Targeting drug chemo-resistance in cancer using natural products","volume":"9","author":"Talib","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbi.2024.111218_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.cbi.2024.111218_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1756-8722-6-88","article-title":"Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics","volume":"6","author":"Akinleye","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib27","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"mTOR complex 2 signaling and functions","volume":"10","author":"Oh","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2024.111218_bib28","series-title":"Protein Phosphorylation as a Key Mechanism of mTORC1\/2 Signaling Pathways, Protein Phosphorylation Hum","author":"Tchevkina","year":"2012"},{"key":"10.1016\/j.cbi.2024.111218_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2024.111218_bib30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2024.111218_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2024.111218_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.774103","article-title":"mTOR-mediated regulation of immune responses in cancer and tumor microenvironment","volume":"12","author":"Mafi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2024.111218_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2024.111218_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800908783497122","article-title":"AKT signaling in regulating angiogenesis","volume":"8","author":"Jiang","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cbi.2024.111218_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04348-5","article-title":"Biological aspects in controlling angiogenesis: current progress","volume":"79","author":"Akbarian","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cbi.2024.111218_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis deregulation and the development of cancer multi-drug resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111218_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.cbi.2024.111218_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00533-2","article-title":"Estrogen\/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive\/HER2-positive breast cancer","volume":"9","author":"Pegram","year":"2023","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2024.111218_bib42","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2024.111218_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100076","article-title":"Non-small-cell lung cancer-associated gene mutations and inhibitors","volume":"6","author":"Kumar","year":"2022","journal-title":"Adv. Cancer Biol. - Metastasis."},{"key":"10.1016\/j.cbi.2024.111218_bib44","doi-asserted-by":"crossref","first-page":"563.e1","DOI":"10.1016\/j.clgc.2021.07.014","article-title":"Targeting the PI3K-AKT-mTOR pathway in castration resistant prostate cancer: a review article","volume":"19","author":"Cham","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib45","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4847","article-title":"Emerging trends in colorectal cancer: dysregulated signaling pathways","volume":"47","author":"Ahmad","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cbi.2024.111218_bib46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cac2.12361","article-title":"An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment","volume":"42","author":"Verdugo","year":"2022","journal-title":"Cancer Commun."},{"issue":"APR","key":"10.1016\/j.cbi.2024.111218_bib47","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.181","article-title":"Small molecule inhibitors targeting the cancers","volume":"3","author":"Liu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.cbi.2024.111218_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14020157","article-title":"Status and challenges of plant-anticancer compounds in cancer treatment","volume":"14","author":"Garcia-Oliveira","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2024.111218_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.18632\/oncotarget.188","article-title":"Targeting the PI3K\/Akt\/mTOR Pathway <unicode>8211<\/unicode> beyond Rapalogs","volume":"1","author":"Markman","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2024.111218_bib52","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.21037\/atm-21-1948","article-title":"A narrative review of tumor heterogeneity and challenges to tumor drug therapy","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cbi.2024.111218_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920974652","article-title":"Biomarkers: opportunities and challenges for drug development in the current regulatory landscape","volume":"15","author":"Gromova","year":"2020","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.cbi.2024.111218_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.fitote.2014.10.010","article-title":"Effect of evodiagenine mediates photocytotoxicity on human breast cancer cells MDA-MB-231 through inhibition of PI3K\/AKT\/mTOR and activation of p38 pathways","volume":"99","author":"Xu","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2024.111218_bib56","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.2147\/DDDT.S216542","article-title":"Indole-2-Carboxamide derivative LG25 inhibits triple-negative breast cancer growth by suppressing akt\/mTOR\/NF-\u03baB signalling pathway","volume":"13","author":"Xu","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2024.111218_bib57","article-title":"Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT\/mTOR and p38 signaling pathways, Biomed","volume":"121","author":"Wei","year":"2020","journal-title":"Pharma"},{"key":"10.1016\/j.cbi.2024.111218_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115986","article-title":"Sinomenine inhibits hypoxia induced breast cancer side population cells metastasis by PI3K\/Akt\/mTOR pathway","volume":"31","author":"Song","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111218_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ptr.7601","article-title":"6-Methoxydihydrosanguinarine induces apoptosis and autophagy in breast cancer MCF-7 cells by accumulating ROS to suppress the PI3K\/AKT\/mTOR signaling pathway","volume":"37","author":"Zhang","year":"2023","journal-title":"Phyther. Res."},{"key":"10.1016\/j.cbi.2024.111218_bib60","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7150\/ijbs.44907","article-title":"Homoharringtonine inhibited breast cancer cells growth via mir-18a-3p\/akt\/mtor signaling pathway","volume":"17","author":"Bin Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216714","article-title":"Harmine hydrochloride mediates the induction of G2\/M cell cycle arrest in breast cancer cells by regulating the MAPKs and AKT\/FOXO3a signaling pathways","volume":"26","author":"Ock","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111218_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154015","article-title":"Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression","volume":"99","author":"Zuo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111218_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119995","article-title":"3-Epipachysamine B suppresses proliferation and induces apoptosis of breast cancer cell via PI3K\/AKT\/mTOR signaling pathway","volume":"285","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174215","article-title":"A novel evodiamine amino derivative as a PI3K\/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells","volume":"906","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib65","first-page":"134","article-title":"Activation of AKT\/ERK confers non-small cell lung cancer cells resistance to vinorelbine","volume":"7","author":"Fan","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cbi.2024.111218_bib66","article-title":"Inhibitory effect and mechanism of hirsuteine on NCI-H1299 lung cancer cell lines, Oncol","volume":"25","author":"Yun","year":"2023","journal-title":"Letture"},{"key":"10.1016\/j.cbi.2024.111218_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fct.2017.10.058","article-title":"Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells","volume":"111","author":"Seok","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2024.111218_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.12.052","article-title":"Anti-lung cancer activity and inhibitory mechanisms of a novel Calothrixin A derivative","volume":"219","author":"Yang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-015-2460-9","article-title":"The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells","volume":"407","author":"Wang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2024.111218_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114864","article-title":"Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K\/AKT\/mTOR and MAPK signaling pathways","volume":"195","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib71","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/cancers6031441","article-title":"The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma","volume":"6","author":"Matsuoka","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111218_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib73","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.3390\/cimb44090298","article-title":"Induction of apoptosis and effect on the FAK\/AKT\/mTOR signal pathway by evodiamine in gastric cancer cells","volume":"44","author":"Yang","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.cbi.2024.111218_bib74","article-title":"Evodiamine inhibits gastric cancer cell proliferation via PTEN-mediated EGF\/PI3K signaling pathway, evidence-based complement","volume":"2021","author":"Yang","year":"2021","journal-title":"Alternative Media"},{"key":"10.1016\/j.cbi.2024.111218_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110618","article-title":"Marine fungus-derived alkaloid inhibits the growth and metastasis of gastric cancer via targeting mTORC1 signaling pathway","volume":"382","author":"Ma","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.111218_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phymed.2017.02.008","article-title":"Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells","volume":"28","author":"Li","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111218_bib77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pharmthera.2013.12.003","article-title":"The role of FAK in tumor metabolism and therapy","volume":"142","author":"Zhang","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2024.111218_bib78","first-page":"891","article-title":"Effects of \u03b2-carboline alkaloids from Peganum harmala on the FAK\/PI3K\/AKT\/Mtor pathway in human gastric cancer cell line SGC-7901 and tumor-bearing mice","volume":"34","author":"Fan","year":"2021","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.616251","article-title":"Berberine improves chemo-sensitivity to cisplatin by enhancing cell apoptosis and repressing PI3K\/AKT\/mTOR signaling pathway in gastric cancer","volume":"11","author":"Kou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.cbi.2024.111218_bib81","article-title":"PI3K\/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells, Cell Commun","volume":"21","author":"Maharati","year":"2023","journal-title":"Signals"},{"key":"10.1016\/j.cbi.2024.111218_bib82","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/bjc.2014.100","article-title":"Activation of the PI3K\/AKT pathway correlates with prognosis in stage II colon cancer","volume":"110","author":"Malinowsky","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib83","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2802037","article-title":"To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway","volume":"28","author":"Zhong","year":"2023","journal-title":"Front. Biosci. - Landmark."},{"key":"10.1016\/j.cbi.2024.111218_bib84","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.7150\/jca.92087","article-title":"Evodiamine inhibits colorectal cancer growth via RTKs mediated PI3K\/AKT\/p53 signaling pathway","volume":"15","author":"Zheng","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib85","article-title":"Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53","volume":"14","author":"Zhang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104693","article-title":"Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K\/AKT\/mTOR pathways","volume":"109","author":"Hu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2024.111218_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-8-100","article-title":"A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy","volume":"8","author":"Nakamura","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib88","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/OTT.S232137","article-title":"Noscapine induces apoptosis in human colon cancer cells by regulating mitochondrial damage and warburg effect via pten\/pi3k\/mtor signaling pathway","volume":"13","author":"Tian","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cbi.2024.111218_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","article-title":"Berberine regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells","volume":"59","author":"Li","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cbi.2024.111218_bib90","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biopha.2018.10.182","article-title":"Piperlongumine, a piper alkaloid targets Ras\/PI3K\/Akt\/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH\/DSS induced experimental colon cancer","volume":"109","author":"Kumar","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111218_bib91","doi-asserted-by":"crossref","DOI":"10.1007\/s11418-023-01769-9","article-title":"Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4\/PI3K\/AKT signaling pathway","author":"Guo","year":"2024","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.cbi.2024.111218_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.procbio.2020.08.026","article-title":"Harnessing WYE-132 as an inhibitor of the mTOR signaling enriches the cytotoxicity effect of vinblastine in B16F10 melanoma cancer cells","volume":"99","author":"Khaki-Khatibi","year":"2020","journal-title":"Process Biochem."},{"key":"10.1016\/j.cbi.2024.111218_bib93","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbrc.2016.09.061","article-title":"Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K\/AKT and RAR\u03b1\/RAR\u03b2 in melanoma cells","volume":"479","author":"Kou","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2024.111218_bib94","article-title":"The inhibitory effects of compound Muniziqi granule against B16 cells and harmine induced autophagy and apoptosis by inhibiting Akt\/mTOR pathway","volume":"17","author":"Zou","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.cbi.2024.111218_bib95","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bcp.2012.01.013","article-title":"Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus\/vinblastine combination in hepatocellular carcinoma","volume":"83","author":"Zhou","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib96","article-title":"Everolimus acts in synergy with vinorelbine to suppress the growth of hepatocellular carcinoma","volume":"25","author":"Huynh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib97","doi-asserted-by":"crossref","first-page":"12255","DOI":"10.1096\/fj.202000254R","article-title":"HTBPI, an active phenanthroindolizidine alkaloid, inhibits liver tumorigenesis by targeting Akt","volume":"34","author":"Liu","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2024.111218_bib98","first-page":"1423","article-title":"Piperlongumine induces apoptosis and autophagy in leukemic cells through targeting the PI3K\/Akt\/mTOR and p38 signaling pathways, Oncol","volume":"15","author":"Wang","year":"2018","journal-title":"Letture"},{"key":"10.1016\/j.cbi.2024.111218_bib99","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/etm.2015.2254","article-title":"Piperlongumine reverses doxorubicin resistance through the PI3K\/Akt signaling pathway in K562\/A02 human leukemia cells","volume":"9","author":"Kang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2024.111218_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108726","article-title":"Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K\/Akt\/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells","volume":"310","author":"Xu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.111218_bib101","first-page":"2891","article-title":"Matrine induces apoptosis in acute myeloid leukemia cells by inhibiting the PI3K\/Akt\/mTOR signaling pathway","volume":"18","author":"Hao","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2024.111218_bib102","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41401-022-01033-y","article-title":"Characterization of LTr1 derived from cruciferous vegetables as a novel anti-glioma agent via inhibiting TrkA\/PI3K\/AKT pathway","volume":"44","author":"qi Song","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2024.111218_bib103","first-page":"867","article-title":"Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR\/PI3K\/Akt\/mTOR signaling pathway and STAT3","volume":"40","author":"Dai","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2024.111218_bib104","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3892\/or.2016.4998","article-title":"Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K\/AKT\/mTOR signaling pathway","volume":"36","author":"Liu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2024.111218_bib105","first-page":"783","article-title":"Effects of evodiamine on PI3K\/Akt and MAPK\/ERK signaling pathways in pancreatic cancer cells","volume":"56","author":"Hong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.8.1","article-title":"Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K\/Akt pathway","volume":"8","author":"Wei","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib107","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.fct.2013.07.062","article-title":"Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway","volume":"60","author":"Fang","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2024.111218_bib108","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biopha.2017.11.064","article-title":"The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K\/AKT\/mTOR pathway","volume":"97","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111218_bib109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00210-016-1217-7","article-title":"Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K\/Akt\/mTOR signaling pathway and NF-\u03baB activation","volume":"389","author":"Bai","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib110","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/tox.23304","article-title":"Brucine promotes apoptosis in cervical cancer cells (ME-180) via suppression of inflammation and cell proliferation by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"36","author":"Seshadri","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.cbi.2024.111218_bib111","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jff.2015.06.006","article-title":"Growth-suppressive effect of berberine on endometrial carcinoma cells: role of mitochondrial and PI3K\/Akt pathway","volume":"17","author":"Kuo","year":"2015","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.cbi.2024.111218_bib112","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pestbp.2018.12.005","article-title":"Natural \u03b2-carboline alkaloids regulate the PI3K\/Akt\/mTOR pathway and induce autophagy in insect Sf9 cells","volume":"154","author":"Cui","year":"2019","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.cbi.2024.111218_bib113","first-page":"15216","article-title":"Evodiamine inhibits proliferation of human papillary thyroid cancer cell line K1 by regulating of PI3K\/Akt signaling pathway","volume":"9","author":"Lv","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cbi.2024.111218_bib114","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.21873\/anticanres.12992","article-title":"Evodiamine suppresses survival, proliferation, migration and epithelial-mesenchymal transition of thyroid carcinoma cells","volume":"38","author":"Kim","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2024.111218_bib115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.cbi.2024.111218_bib116","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2024.111218_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080803","article-title":"Role and therapeutic targeting of the pi3k\/akt\/mtor signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents therapy","volume":"8","author":"Chamcheu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2024.111218_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512224","article-title":"Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment","volume":"24","author":"Foglia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106553","article-title":"Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and Challenges","volume":"187","author":"Paskeh","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111218_bib120","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-020-00396-1","article-title":"MTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cbi.2024.111218_bib121","article-title":"Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development","volume":"16","author":"fu Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174434","article-title":"Targeting pi3k pathway in pancreatic ductal adenocarcinoma: rationale and progress","volume":"13","author":"Mehra","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111218_bib123","article-title":"PI3K\/AKT\/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer","volume":"18","author":"Wang","year":"2023","journal-title":"Open Life Sci."},{"key":"10.1016\/j.cbi.2024.111218_bib124","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/10799893.2022.2123515","article-title":"Identification of novel mycocompounds as inhibitors of PI3K\/AKT\/mTOR pathway against RCC","volume":"42","author":"Yadav","year":"2022","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.cbi.2024.111218_bib125","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-03073-8","article-title":"FAP promotes clear cell renal cell carcinoma progression via activating the PI3K\/AKT\/mTOR signaling pathway","volume":"23","author":"Jiang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cbi.2024.111218_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108461","article-title":"Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K\/AKT\/mTOR pathway involved","volume":"689","author":"Bian","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2024.111218_bib127","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1200\/JCO.2007.12.5641","article-title":"Phase II study of vinflunine in malignant pleural mesothelioma","volume":"25","author":"Talbot","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib128","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/JTO.0b013e3181d86b76","article-title":"Phase II trial of vinflunine in relapsed small cell lung cancer","volume":"5","author":"Spigel","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00280-016-3226-0","article-title":"Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer","volume":"79","author":"Tabchi","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00280-014-2600-z","article-title":"Phase i clinical trial of temsirolimus and vinorelbine in advanced solid tumors","volume":"74","author":"Piatek","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111218_bib131","first-page":"1907","article-title":"Vinorelbine- a clinical review","volume":"82","author":"Gregory","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2024.111218_bib132","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2017.10.041","article-title":"New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111218_bib133","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a european multicenter trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib134","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/JTO.0b013e3181cee24f","article-title":"Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer","volume":"5","author":"Chiappori","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2024.111218_bib135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1749-6632.1996.tb26392.x","article-title":"Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents","volume":"803","author":"Natelson","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:13:46Z","timestamp":1725927226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724003648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":135,"alternative-id":["S0009279724003648"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111218","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alkaloid-based modulators of the PI3K\/Akt\/mTOR pathway for cancer therapy: Understandings from pharmacological point of view","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111218"}}